RecruitingNCT06532721

Child Development and Genetic Biomarkers(II): Gene Verification and Data Integration


Sponsor

Chang Gung Memorial Hospital

Enrollment

525 participants

Start Date

Dec 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The aims of the study include (1) identifying genes associated with child development and developmental delay in Taiwan (2) comparing the differences and similarities between genetic biomarkers of development and developmental delay for children in Taiwan and children from other countries (3) employing precision medicine as the method for genetic screening or test and (4) tracking children's biological, psychological and social adjustment, especially for those who have early-onset developmental delay.


Eligibility

Max Age: 40 Years

Inclusion Criteria3

  • Consent signing
  • -40 years old
  • Typical development or developmental disabilities

Exclusion Criteria4

  • Central Nervous disease
  • Neuromuscular disease
  • Congenital disease
  • Sensory disorder such as blindness or hearing impairment

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Chang Gung Memorial Hospital

Taoyuan, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06532721


Related Trials